Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases

Clinical and Experimental Rheumatology

Volumn 17, Issue 5, 1999, Pages 585-591

  Danieli, M G ^a   Fraticelli, P ^a   Franceschini, F ^b   Cattaneo, R ^b   Farsi, A ^c   Passaleva, A ^c   Pietrogrande, M ^d   Invernizzi, F ^d   Vanoli, M ^e   Scorza, R ^e   Sabbadini, M G ^f   Gerli, R ^g   Corvetta, A ^h   Farina, G ⁱ   Salsano, F ⁱ   Priori, R ⁱ   Valesini, G ⁱ   Danieli, G ^a  

^a Ematologia ed Immunologia Clinica   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d DSM San Paolo Milano   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g UNIVERSITY OF PERUGIA   (Italy)

^h Ospedale degli Infermi di Rimini   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autoimmune diseases; Connective tissue diseases (CTDs); Outcome; Undifferentiated CTD

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RAYNAUD DISEASE; STEROIDS; TREATMENT OUTCOME; VASCULITIS;

EID: 6544271524     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
2. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-77.
3. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE ARA DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
4. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al.: Preliminary criteria for the classification of the Sjögren's syndrome. Arthritis Rheum 1993; 36: 340-7.
5. BOHAN A, PETER JB: Polymyositis and dermatomyositis. New Engl J Med 1975; 292: 344-7 and 403-7.
6. SHARP GC: Diagnostic criteria for classification of MCTD. In: KASUKAWA R and SHARP GC (Eds.): MCTD and Anti-Nuclear Antibodies. Amsterdam, Elsevier, 1987: 23-32.
7. KALLENBERG CGM: Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions. Current Op Rheumatol 1995; 7: 568-73.
8. MUKERJI B, HARDIN JG: Undifferentiated, overlapping and mixed connective tissue disease. Am J Med Sci 1993; 305: 114-9.
9. ALARCÓN GS, WILLIAMS GV, SINGER JZ et al.: Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. J Rheumatol 1991; 18: 1332-9.
10. BLACK C, ISENBERO DA: Mixed connective tissue disease - Goodbye to all that. Br J Rheumatol 1992; 31: 695-700.
11. ASHERSON RA, KHAMASHTA MA, ORDIROS J et al.: The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-74.
12. GOREVIC PD, KASSAB PJ, LEVO Y et al.: Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287-308.
13. THE INTERNATIONAL STUDY GROUP FOR BEHÇET's DISEASE: Evaluation of the diagnostic (classification) criteria in Behçet's disease - Towards internationally agreed criteria. Br J Rheumatol 1992; 31: 299-308.
14. DOUGADOS M, VAN DER LINDEN S, JUHLIN R et al.: The European Spondylarthropathy Study Group preliminary criteria for the classification of Spondylarthropathy. Arthritis Rheum 1991; 34: 1218-27.
15. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990; 33: 1065-121.
16. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al.: Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. Ann Rheum Dis 1996; 55: 116-21.
17. BERNSTEIN RM, BUNN CC, HUGHES GRV: Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 1987; 41: 554-5.
18. SEQUI J, LEIGH I, ISENBERG DA: Relation between antinuclear antibodies and the autoimmune rheumatic diseases and disease type and activity in SLE using a variety of cultured cell lines. Ann Rheum Dis 1991; 50: 167-72.
19. HARRIS EN: The Second International AntiCardiolipin Standardisation Workshop/The Kaps Group. Am J Clin Pathol 1990; 94: 476-84.
20. WIIK A: Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97 (Suppl. 6): 12S.
21. CLEGG DO, WILLIAMS HJ, SINGER JZ et al.: Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1991; 18: 1340-3.
22. BULPITT KJ, CLEMENTS PJ, LACHENBRUCH PA et al.: Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis) Ann Intern Med 1993; 118: 602-9.
23. ALARCÓN GS, WILKENS RF, WARD JR et al.: Early undifferentiated connective tissue disease. IV Muscoloskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease: Follow-up analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Arthritis Rheum 1996; 39: 403-14.
24. CALVO-ALÉN J, ALARCÓN GS, BURGARD SL, BURST N, BARTOLUCCI AA, WILLIAMS HJ: Systemic lupus erythematosus: Predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: Multivariate analyses and identification of risk factors. J Rheumatol 1996; 23: 469-75.
25. MOSCA M, TAVONI A, NERI R, BENCIVELLI W, BOMBARDIERI S: Undifferentiated connective tissue diseases: The clinical and serological profiles in 91 patients followed for at least 1 year. Lupus 1998; 7: 95-100.
26. DANIELI MG, FRATICELLI P, SALVI A, GABRIELLI A, DANIELI G: Undifferentiated connective tissue disease: Natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 1998; 17: 195-201.
27. NERI R, TAVONI A, CRISTOFANI R et al.: Antinuclear antibody profile in Italian patients with connective tissue disease. Lupus 1992; 1: 221-7.
28. CAPORALI R, SCATOLA C, MONTECUCCO C: Benign hypergammaglobulinemic burpura and anti-Ro (SSA) antibodies in undifferentiated connective tissue disease. J Rheumatol 1996; 23: 410-1.
29. GERLI R, MUSCAT C, GIANSANTI M et al.: Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: Its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol 1997; 36: 969-75.
30. GANCZARCZYK, UROWITZ MB, GLADMAN DD: "Latent lupus". J Rheumatol 1989; 16: 475-8.
31. GERBRACHT DD, STEEN VD, ZIEGLER GL, MEDSGER TA JR, RODNAN GP: Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985; 28: 87-92.
32. WOLLERSHEIM H, THIEN TH, HOET MH, VAN VENROOY WJ: The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon. Eur J Clin Invest 1989; 19: 535-41.
33. HARPER FE, MARICQ HR, TURNER RE, LIDMAN RW, LEROY EC: A prospective study of Raynaud phenomenon and early connective tissue disease. Am J Med 1982; 72: 883-8.